img

Global Monoclonal Antibody Treatment Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Monoclonal Antibody Treatment Market Insights, Forecast to 2034

Monoclonal antibody treatment is a type of targeted therapy that uses specific antibodies to identify and attack cancer cells or other diseased cells in the body.
Market Analysis and InsightsGlobal Monoclonal Antibody Treatment Market
Global Monoclonal Antibody Treatment market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Monoclonal Antibody Treatment industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
The market for monoclonal antibody treatment is driven by the increasing demand for personalized and targeted cancer therapies and the growing prevalence of various cancers and autoimmune diseases. The market's growth is also influenced by ongoing research and development in monoclonal antibodies, leading to the discovery of new therapeutic targets and treatment options.
Report Covers
This report presents an overview of global Monoclonal Antibody Treatment market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Monoclonal Antibody Treatment market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Pfizer
Bayer
Sanofi
Merck
GlaxoSmithKline
Roche
Novartis
AbbVie
Shanghai Junshi Biosciences Co.,Ltd
Innovent Biologics
Jiangsu Hengrui Medicine Co.,Ltd.
BeiGene, Ltd.
Grand Pharmaceutical (China) Co., Ltd
Henlius
Segment by Type
Cancer
Autoimmune Diseases
Exogenous Infection
Hematological Diseases

Segment by Application


Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Monoclonal Antibody Treatment introduction, etc. Monoclonal Antibody Treatment Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Monoclonal Antibody Treatment
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Monoclonal Antibody Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Cancer
1.2.3 Autoimmune Diseases
1.2.4 Exogenous Infection
1.2.5 Hematological Diseases
1.3 Market by Application
1.3.1 Global Monoclonal Antibody Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Monoclonal Antibody Treatment Market Perspective (2018-2029)
2.2 Global Monoclonal Antibody Treatment Growth Trends by Region
2.2.1 Monoclonal Antibody Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Monoclonal Antibody Treatment Historic Market Size by Region (2018-2024)
2.2.3 Monoclonal Antibody Treatment Forecasted Market Size by Region (2024-2029)
2.3 Monoclonal Antibody Treatment Market Dynamics
2.3.1 Monoclonal Antibody Treatment Industry Trends
2.3.2 Monoclonal Antibody Treatment Market Drivers
2.3.3 Monoclonal Antibody Treatment Market Challenges
2.3.4 Monoclonal Antibody Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Monoclonal Antibody Treatment by Players
3.1.1 Global Monoclonal Antibody Treatment Revenue by Players (2018-2024)
3.1.2 Global Monoclonal Antibody Treatment Revenue Market Share by Players (2018-2024)
3.2 Global Monoclonal Antibody Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Monoclonal Antibody Treatment, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Monoclonal Antibody Treatment Market Concentration Ratio
3.4.1 Global Monoclonal Antibody Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Monoclonal Antibody Treatment Revenue in 2022
3.5 Global Key Players of Monoclonal Antibody Treatment Head office and Area Served
3.6 Global Key Players of Monoclonal Antibody Treatment, Product and Application
3.7 Global Key Players of Monoclonal Antibody Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Monoclonal Antibody Treatment Breakdown Data by Type
4.1 Global Monoclonal Antibody Treatment Historic Market Size by Type (2018-2024)
4.2 Global Monoclonal Antibody Treatment Forecasted Market Size by Type (2024-2029)
5 Monoclonal Antibody Treatment Breakdown Data by Application
5.1 Global Monoclonal Antibody Treatment Historic Market Size by Application (2018-2024)
5.2 Global Monoclonal Antibody Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Monoclonal Antibody Treatment Market Size (2018-2029)
6.2 North America Monoclonal Antibody Treatment Market Size by Type
6.2.1 North America Monoclonal Antibody Treatment Market Size by Type (2018-2024)
6.2.2 North America Monoclonal Antibody Treatment Market Size by Type (2024-2029)
6.2.3 North America Monoclonal Antibody Treatment Market Share by Type (2018-2029)
6.3 North America Monoclonal Antibody Treatment Market Size by Application
6.3.1 North America Monoclonal Antibody Treatment Market Size by Application (2018-2024)
6.3.2 North America Monoclonal Antibody Treatment Market Size by Application (2024-2029)
6.3.3 North America Monoclonal Antibody Treatment Market Share by Application (2018-2029)
6.4 North America Monoclonal Antibody Treatment Market Size by Country
6.4.1 North America Monoclonal Antibody Treatment Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Monoclonal Antibody Treatment Market Size by Country (2018-2024)
6.4.3 North America Monoclonal Antibody Treatment Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Monoclonal Antibody Treatment Market Size (2018-2029)
7.2 Europe Monoclonal Antibody Treatment Market Size by Type
7.2.1 Europe Monoclonal Antibody Treatment Market Size by Type (2018-2024)
7.2.2 Europe Monoclonal Antibody Treatment Market Size by Type (2024-2029)
7.2.3 Europe Monoclonal Antibody Treatment Market Share by Type (2018-2029)
7.3 Europe Monoclonal Antibody Treatment Market Size by Application
7.3.1 Europe Monoclonal Antibody Treatment Market Size by Application (2018-2024)
7.3.2 Europe Monoclonal Antibody Treatment Market Size by Application (2024-2029)
7.3.3 Europe Monoclonal Antibody Treatment Market Share by Application (2018-2029)
7.4 Europe Monoclonal Antibody Treatment Market Size by Country
7.4.1 Europe Monoclonal Antibody Treatment Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Monoclonal Antibody Treatment Market Size by Country (2018-2024)
7.4.3 Europe Monoclonal Antibody Treatment Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Monoclonal Antibody Treatment Market Size (2018-2029)
8.2 China Monoclonal Antibody Treatment Market Size by Type
8.2.1 China Monoclonal Antibody Treatment Market Size by Type (2018-2024)
8.2.2 China Monoclonal Antibody Treatment Market Size by Type (2024-2029)
8.2.3 China Monoclonal Antibody Treatment Market Share by Type (2018-2029)
8.3 China Monoclonal Antibody Treatment Market Size by Application
8.3.1 China Monoclonal Antibody Treatment Market Size by Application (2018-2024)
8.3.2 China Monoclonal Antibody Treatment Market Size by Application (2024-2029)
8.3.3 China Monoclonal Antibody Treatment Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Monoclonal Antibody Treatment Market Size (2018-2029)
9.2 Asia Monoclonal Antibody Treatment Market Size by Type
9.2.1 Asia Monoclonal Antibody Treatment Market Size by Type (2018-2024)
9.2.2 Asia Monoclonal Antibody Treatment Market Size by Type (2024-2029)
9.2.3 Asia Monoclonal Antibody Treatment Market Share by Type (2018-2029)
9.3 Asia Monoclonal Antibody Treatment Market Size by Application
9.3.1 Asia Monoclonal Antibody Treatment Market Size by Application (2018-2024)
9.3.2 Asia Monoclonal Antibody Treatment Market Size by Application (2024-2029)
9.3.3 Asia Monoclonal Antibody Treatment Market Share by Application (2018-2029)
9.4 Asia Monoclonal Antibody Treatment Market Size by Region
9.4.1 Asia Monoclonal Antibody Treatment Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Monoclonal Antibody Treatment Market Size by Region (2018-2024)
9.4.3 Asia Monoclonal Antibody Treatment Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Monoclonal Antibody Treatment Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Monoclonal Antibody Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America Monoclonal Antibody Treatment Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Monoclonal Antibody Treatment Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Monoclonal Antibody Treatment Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Monoclonal Antibody Treatment Market Size by Application
10.3.1 Middle East, Africa, and Latin America Monoclonal Antibody Treatment Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Monoclonal Antibody Treatment Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Monoclonal Antibody Treatment Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Monoclonal Antibody Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America Monoclonal Antibody Treatment Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Monoclonal Antibody Treatment Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Monoclonal Antibody Treatment Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Monoclonal Antibody Treatment Introduction
11.1.4 Pfizer Revenue in Monoclonal Antibody Treatment Business (2018-2024)
11.1.5 Pfizer Recent Developments
11.2 Bayer
11.2.1 Bayer Company Details
11.2.2 Bayer Business Overview
11.2.3 Bayer Monoclonal Antibody Treatment Introduction
11.2.4 Bayer Revenue in Monoclonal Antibody Treatment Business (2018-2024)
11.2.5 Bayer Recent Developments
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Monoclonal Antibody Treatment Introduction
11.3.4 Sanofi Revenue in Monoclonal Antibody Treatment Business (2018-2024)
11.3.5 Sanofi Recent Developments
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Monoclonal Antibody Treatment Introduction
11.4.4 Merck Revenue in Monoclonal Antibody Treatment Business (2018-2024)
11.4.5 Merck Recent Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Monoclonal Antibody Treatment Introduction
11.5.4 GlaxoSmithKline Revenue in Monoclonal Antibody Treatment Business (2018-2024)
11.5.5 GlaxoSmithKline Recent Developments
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Monoclonal Antibody Treatment Introduction
11.6.4 Roche Revenue in Monoclonal Antibody Treatment Business (2018-2024)
11.6.5 Roche Recent Developments
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Monoclonal Antibody Treatment Introduction
11.7.4 Novartis Revenue in Monoclonal Antibody Treatment Business (2018-2024)
11.7.5 Novartis Recent Developments
11.8 AbbVie
11.8.1 AbbVie Company Details
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Monoclonal Antibody Treatment Introduction
11.8.4 AbbVie Revenue in Monoclonal Antibody Treatment Business (2018-2024)
11.8.5 AbbVie Recent Developments
11.9 Shanghai Junshi Biosciences Co.,Ltd
11.9.1 Shanghai Junshi Biosciences Co.,Ltd Company Details
11.9.2 Shanghai Junshi Biosciences Co.,Ltd Business Overview
11.9.3 Shanghai Junshi Biosciences Co.,Ltd Monoclonal Antibody Treatment Introduction
11.9.4 Shanghai Junshi Biosciences Co.,Ltd Revenue in Monoclonal Antibody Treatment Business (2018-2024)
11.9.5 Shanghai Junshi Biosciences Co.,Ltd Recent Developments
11.10 Innovent Biologics
11.10.1 Innovent Biologics Company Details
11.10.2 Innovent Biologics Business Overview
11.10.3 Innovent Biologics Monoclonal Antibody Treatment Introduction
11.10.4 Innovent Biologics Revenue in Monoclonal Antibody Treatment Business (2018-2024)
11.10.5 Innovent Biologics Recent Developments
11.11 Jiangsu Hengrui Medicine Co.,Ltd.
11.11.1 Jiangsu Hengrui Medicine Co.,Ltd. Company Details
11.11.2 Jiangsu Hengrui Medicine Co.,Ltd. Business Overview
11.11.3 Jiangsu Hengrui Medicine Co.,Ltd. Monoclonal Antibody Treatment Introduction
11.11.4 Jiangsu Hengrui Medicine Co.,Ltd. Revenue in Monoclonal Antibody Treatment Business (2018-2024)
11.11.5 Jiangsu Hengrui Medicine Co.,Ltd. Recent Developments
11.12 BeiGene, Ltd.
11.12.1 BeiGene, Ltd. Company Details
11.12.2 BeiGene, Ltd. Business Overview
11.12.3 BeiGene, Ltd. Monoclonal Antibody Treatment Introduction
11.12.4 BeiGene, Ltd. Revenue in Monoclonal Antibody Treatment Business (2018-2024)
11.12.5 BeiGene, Ltd. Recent Developments
11.13 Grand Pharmaceutical (China) Co., Ltd
11.13.1 Grand Pharmaceutical (China) Co., Ltd Company Details
11.13.2 Grand Pharmaceutical (China) Co., Ltd Business Overview
11.13.3 Grand Pharmaceutical (China) Co., Ltd Monoclonal Antibody Treatment Introduction
11.13.4 Grand Pharmaceutical (China) Co., Ltd Revenue in Monoclonal Antibody Treatment Business (2018-2024)
11.13.5 Grand Pharmaceutical (China) Co., Ltd Recent Developments
11.14 Henlius
11.14.1 Henlius Company Details
11.14.2 Henlius Business Overview
11.14.3 Henlius Monoclonal Antibody Treatment Introduction
11.14.4 Henlius Revenue in Monoclonal Antibody Treatment Business (2018-2024)
11.14.5 Henlius Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Monoclonal Antibody Treatment Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Cancer
Table 3. Key Players of Autoimmune Diseases
Table 4. Key Players of Exogenous Infection
Table 5. Key Players of Hematological Diseases
Table 6. Global Monoclonal Antibody Treatment Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 7. Global Monoclonal Antibody Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Monoclonal Antibody Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 9. Global Monoclonal Antibody Treatment Market Share by Region (2018-2024)
Table 10. Global Monoclonal Antibody Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Monoclonal Antibody Treatment Market Share by Region (2024-2029)
Table 12. Monoclonal Antibody Treatment Market Trends
Table 13. Monoclonal Antibody Treatment Market Drivers
Table 14. Monoclonal Antibody Treatment Market Challenges
Table 15. Monoclonal Antibody Treatment Market Restraints
Table 16. Global Monoclonal Antibody Treatment Revenue by Players (2018-2024) & (US$ Million)
Table 17. Global Monoclonal Antibody Treatment Revenue Share by Players (2018-2024)
Table 18. Global Top Monoclonal Antibody Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibody Treatment as of 2022)
Table 19. Global Monoclonal Antibody Treatment Industry Ranking 2021 VS 2022 VS 2024
Table 20. Global 5 Largest Players Market Share by Monoclonal Antibody Treatment Revenue (CR5 and HHI) & (2018-2024)
Table 21. Global Key Players of Monoclonal Antibody Treatment, Headquarters and Area Served
Table 22. Global Key Players of Monoclonal Antibody Treatment, Product and Application
Table 23. Global Key Players of Monoclonal Antibody Treatment, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Monoclonal Antibody Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 26. Global Monoclonal Antibody Treatment Revenue Market Share by Type (2018-2024)
Table 27. Global Monoclonal Antibody Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Monoclonal Antibody Treatment Revenue Market Share by Type (2024-2029)
Table 29. Global Monoclonal Antibody Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 30. Global Monoclonal Antibody Treatment Revenue Share by Application (2018-2024)
Table 31. Global Monoclonal Antibody Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Monoclonal Antibody Treatment Revenue Share by Application (2024-2029)
Table 33. North America Monoclonal Antibody Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 34. North America Monoclonal Antibody Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 35. North America Monoclonal Antibody Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 36. North America Monoclonal Antibody Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 37. North America Monoclonal Antibody Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. North America Monoclonal Antibody Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 39. North America Monoclonal Antibody Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 40. Europe Monoclonal Antibody Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 41. Europe Monoclonal Antibody Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 42. Europe Monoclonal Antibody Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 43. Europe Monoclonal Antibody Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 44. Europe Monoclonal Antibody Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Europe Monoclonal Antibody Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 46. Europe Monoclonal Antibody Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 47. China Monoclonal Antibody Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 48. China Monoclonal Antibody Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 49. China Monoclonal Antibody Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 50. China Monoclonal Antibody Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 51. Asia Monoclonal Antibody Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 52. Asia Monoclonal Antibody Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 53. Asia Monoclonal Antibody Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 54. Asia Monoclonal Antibody Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 55. Asia Monoclonal Antibody Treatment Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 56. Asia Monoclonal Antibody Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 57. Asia Monoclonal Antibody Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Monoclonal Antibody Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Monoclonal Antibody Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Monoclonal Antibody Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Monoclonal Antibody Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Monoclonal Antibody Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 63. Middle East, Africa, and Latin America Monoclonal Antibody Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Monoclonal Antibody Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 65. Pfizer Company Details
Table 66. Pfizer Business Overview
Table 67. Pfizer Monoclonal Antibody Treatment Product
Table 68. Pfizer Revenue in Monoclonal Antibody Treatment Business (2018-2024) & (US$ Million)
Table 69. Pfizer Recent Developments
Table 70. Bayer Company Details
Table 71. Bayer Business Overview
Table 72. Bayer Monoclonal Antibody Treatment Product
Table 73. Bayer Revenue in Monoclonal Antibody Treatment Business (2018-2024) & (US$ Million)
Table 74. Bayer Recent Developments
Table 75. Sanofi Company Details
Table 76. Sanofi Business Overview
Table 77. Sanofi Monoclonal Antibody Treatment Product
Table 78. Sanofi Revenue in Monoclonal Antibody Treatment Business (2018-2024) & (US$ Million)
Table 79. Sanofi Recent Developments
Table 80. Merck Company Details
Table 81. Merck Business Overview
Table 82. Merck Monoclonal Antibody Treatment Product
Table 83. Merck Revenue in Monoclonal Antibody Treatment Business (2018-2024) & (US$ Million)
Table 84. Merck Recent Developments
Table 85. GlaxoSmithKline Company Details
Table 86. GlaxoSmithKline Business Overview
Table 87. GlaxoSmithKline Monoclonal Antibody Treatment Product
Table 88. GlaxoSmithKline Revenue in Monoclonal Antibody Treatment Business (2018-2024) & (US$ Million)
Table 89. GlaxoSmithKline Recent Developments
Table 90. Roche Company Details
Table 91. Roche Business Overview
Table 92. Roche Monoclonal Antibody Treatment Product
Table 93. Roche Revenue in Monoclonal Antibody Treatment Business (2018-2024) & (US$ Million)
Table 94. Roche Recent Developments
Table 95. Novartis Company Details
Table 96. Novartis Business Overview
Table 97. Novartis Monoclonal Antibody Treatment Product
Table 98. Novartis Revenue in Monoclonal Antibody Treatment Business (2018-2024) & (US$ Million)
Table 99. Novartis Recent Developments
Table 100. AbbVie Company Details
Table 101. AbbVie Business Overview
Table 102. AbbVie Monoclonal Antibody Treatment Product
Table 103. AbbVie Revenue in Monoclonal Antibody Treatment Business (2018-2024) & (US$ Million)
Table 104. AbbVie Recent Developments
Table 105. Shanghai Junshi Biosciences Co.,Ltd Company Details
Table 106. Shanghai Junshi Biosciences Co.,Ltd Business Overview
Table 107. Shanghai Junshi Biosciences Co.,Ltd Monoclonal Antibody Treatment Product
Table 108. Shanghai Junshi Biosciences Co.,Ltd Revenue in Monoclonal Antibody Treatment Business (2018-2024) & (US$ Million)
Table 109. Shanghai Junshi Biosciences Co.,Ltd Recent Developments
Table 110. Innovent Biologics Company Details
Table 111. Innovent Biologics Business Overview
Table 112. Innovent Biologics Monoclonal Antibody Treatment Product
Table 113. Innovent Biologics Revenue in Monoclonal Antibody Treatment Business (2018-2024) & (US$ Million)
Table 114. Innovent Biologics Recent Developments
Table 115. Jiangsu Hengrui Medicine Co.,Ltd. Company Details
Table 116. Jiangsu Hengrui Medicine Co.,Ltd. Business Overview
Table 117. Jiangsu Hengrui Medicine Co.,Ltd. Monoclonal Antibody Treatment Product
Table 118. Jiangsu Hengrui Medicine Co.,Ltd. Revenue in Monoclonal Antibody Treatment Business (2018-2024) & (US$ Million)
Table 119. Jiangsu Hengrui Medicine Co.,Ltd. Recent Developments
Table 120. BeiGene, Ltd. Company Details
Table 121. BeiGene, Ltd. Business Overview
Table 122. BeiGene, Ltd. Monoclonal Antibody Treatment Product
Table 123. BeiGene, Ltd. Revenue in Monoclonal Antibody Treatment Business (2018-2024) & (US$ Million)
Table 124. BeiGene, Ltd. Recent Developments
Table 125. Grand Pharmaceutical (China) Co., Ltd Company Details
Table 126. Grand Pharmaceutical (China) Co., Ltd Business Overview
Table 127. Grand Pharmaceutical (China) Co., Ltd Monoclonal Antibody Treatment Product
Table 128. Grand Pharmaceutical (China) Co., Ltd Revenue in Monoclonal Antibody Treatment Business (2018-2024) & (US$ Million)
Table 129. Grand Pharmaceutical (China) Co., Ltd Recent Developments
Table 130. Henlius Company Details
Table 131. Henlius Business Overview
Table 132. Henlius Monoclonal Antibody Treatment Product
Table 133. Henlius Revenue in Monoclonal Antibody Treatment Business (2018-2024) & (US$ Million)
Table 134. Henlius Recent Developments
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Monoclonal Antibody Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Monoclonal Antibody Treatment Market Share by Type: 2022 VS 2029
Figure 3. Cancer Features
Figure 4. Autoimmune Diseases Features
Figure 5. Exogenous Infection Features
Figure 6. Hematological Diseases Features
Figure 7. Global Monoclonal Antibody Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Monoclonal Antibody Treatment Market Share by Application: 2022 VS 2029
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Others Case Studies
Figure 12. Monoclonal Antibody Treatment Report Years Considered
Figure 13. Global Monoclonal Antibody Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Monoclonal Antibody Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Monoclonal Antibody Treatment Market Share by Region: 2022 VS 2029
Figure 16. Global Monoclonal Antibody Treatment Market Share by Players in 2022
Figure 17. Global Top Monoclonal Antibody Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibody Treatment as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Monoclonal Antibody Treatment Revenue in 2022
Figure 19. North America Monoclonal Antibody Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Monoclonal Antibody Treatment Market Share by Type (2018-2029)
Figure 21. North America Monoclonal Antibody Treatment Market Share by Application (2018-2029)
Figure 22. North America Monoclonal Antibody Treatment Market Share by Country (2018-2029)
Figure 23. United States Monoclonal Antibody Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Monoclonal Antibody Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Monoclonal Antibody Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 26. Europe Monoclonal Antibody Treatment Market Share by Type (2018-2029)
Figure 27. Europe Monoclonal Antibody Treatment Market Share by Application (2018-2029)
Figure 28. Europe Monoclonal Antibody Treatment Market Share by Country (2018-2029)
Figure 29. Germany Monoclonal Antibody Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France Monoclonal Antibody Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. Monoclonal Antibody Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy Monoclonal Antibody Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia Monoclonal Antibody Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries Monoclonal Antibody Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. China Monoclonal Antibody Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 36. China Monoclonal Antibody Treatment Market Share by Type (2018-2029)
Figure 37. China Monoclonal Antibody Treatment Market Share by Application (2018-2029)
Figure 38. Asia Monoclonal Antibody Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 39. Asia Monoclonal Antibody Treatment Market Share by Type (2018-2029)
Figure 40. Asia Monoclonal Antibody Treatment Market Share by Application (2018-2029)
Figure 41. Asia Monoclonal Antibody Treatment Market Share by Region (2018-2029)
Figure 42. Japan Monoclonal Antibody Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. South Korea Monoclonal Antibody Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. China Taiwan Monoclonal Antibody Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Southeast Asia Monoclonal Antibody Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. India Monoclonal Antibody Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Australia Monoclonal Antibody Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Monoclonal Antibody Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Monoclonal Antibody Treatment Market Share by Type (2018-2029)
Figure 50. Middle East, Africa, and Latin America Monoclonal Antibody Treatment Market Share by Application (2018-2029)
Figure 51. Middle East, Africa, and Latin America Monoclonal Antibody Treatment Market Share by Country (2018-2029)
Figure 52. Brazil Monoclonal Antibody Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Mexico Monoclonal Antibody Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Turkey Monoclonal Antibody Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Saudi Arabia Monoclonal Antibody Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Israel Monoclonal Antibody Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. GCC Countries Monoclonal Antibody Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Pfizer Revenue Growth Rate in Monoclonal Antibody Treatment Business (2018-2024)
Figure 59. Bayer Revenue Growth Rate in Monoclonal Antibody Treatment Business (2018-2024)
Figure 60. Sanofi Revenue Growth Rate in Monoclonal Antibody Treatment Business (2018-2024)
Figure 61. Merck Revenue Growth Rate in Monoclonal Antibody Treatment Business (2018-2024)
Figure 62. GlaxoSmithKline Revenue Growth Rate in Monoclonal Antibody Treatment Business (2018-2024)
Figure 63. Roche Revenue Growth Rate in Monoclonal Antibody Treatment Business (2018-2024)
Figure 64. Novartis Revenue Growth Rate in Monoclonal Antibody Treatment Business (2018-2024)
Figure 65. AbbVie Revenue Growth Rate in Monoclonal Antibody Treatment Business (2018-2024)
Figure 66. Shanghai Junshi Biosciences Co.,Ltd Revenue Growth Rate in Monoclonal Antibody Treatment Business (2018-2024)
Figure 67. Innovent Biologics Revenue Growth Rate in Monoclonal Antibody Treatment Business (2018-2024)
Figure 68. Jiangsu Hengrui Medicine Co.,Ltd. Revenue Growth Rate in Monoclonal Antibody Treatment Business (2018-2024)
Figure 69. BeiGene, Ltd. Revenue Growth Rate in Monoclonal Antibody Treatment Business (2018-2024)
Figure 70. Grand Pharmaceutical (China) Co., Ltd Revenue Growth Rate in Monoclonal Antibody Treatment Business (2018-2024)
Figure 71. Henlius Revenue Growth Rate in Monoclonal Antibody Treatment Business (2018-2024)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries